Polycystic liver diseases: advanced insights into the molecular mechanisms
about
MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and TreatmentEvidence for a "Pathogenic Triumvirate" in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney DiseasePrimary Cilia in Tumor Biology: The Primary Cilium as a Therapeutic Target in Cholangiocarcinoma.Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.Therapeutic Targets in Polycystic Liver Disease.TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling.Molecular diagnosis of autosomal dominant polycystic kidney disease.Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis.The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease.Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target.The combination of an HDAC6 inhibitor and a somatostatin receptor agonist synergistically reduces hepato-renal cystogenesis in an animal model of polycystic liver disease.Polycystic Liver Disease: The interplay of genes causative for hepatic and renal cystogenesis.Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.Infectious Hepatic Cyst: An Underestimated Complication.
P2860
Q26783579-F6EFF901-F375-4753-9299-378430DBD54AQ28079756-85400F66-77F7-4652-AFC6-445B134D2BE3Q33894574-7C8FC87F-1F56-415C-AD6E-A8E613D9C353Q36075389-43EE2DCD-3B84-40A9-AA75-FDF01758448CQ38443908-58AA65E0-C9B3-4E02-A6EA-770A104C9AD6Q38764445-8ABED801-B784-4F36-BAF7-774FF94B4A0BQ39445724-842C5E83-F7DF-426E-A547-194EB90E89F1Q44519452-97955508-CA35-4BFA-9771-4EC6EA6821FCQ45354626-7AE9CEA6-C276-4AC4-84D3-923BDBE2EAEBQ47662845-7562C8A5-9C1F-47BE-BB84-FF2695DF54FCQ49795322-A681CEEC-328A-450C-8E48-59519DC12145Q50048998-87D6AD16-B284-493F-BAB7-3758599CFEEFQ50110106-6FBFA9EC-7A7C-414B-A7E2-BA1D8F7674AEQ54258308-D31F7B1C-3F50-4937-8A74-63BB6B1FF180
P2860
Polycystic liver diseases: advanced insights into the molecular mechanisms
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Polycystic liver diseases: advanced insights into the molecular mechanisms
@ast
Polycystic liver diseases: advanced insights into the molecular mechanisms
@en
Polycystic liver diseases: advanced insights into the molecular mechanisms
@nl
type
label
Polycystic liver diseases: advanced insights into the molecular mechanisms
@ast
Polycystic liver diseases: advanced insights into the molecular mechanisms
@en
Polycystic liver diseases: advanced insights into the molecular mechanisms
@nl
prefLabel
Polycystic liver diseases: advanced insights into the molecular mechanisms
@ast
Polycystic liver diseases: advanced insights into the molecular mechanisms
@en
Polycystic liver diseases: advanced insights into the molecular mechanisms
@nl
P2093
P2860
P50
P1476
Polycystic liver diseases: advanced insights into the molecular mechanisms
@en
P2093
Marco Marzioni
Maria J Perugorria
Nicholas F LaRusso
Tatyana V Masyuk
P2860
P2888
P304
P356
10.1038/NRGASTRO.2014.155
P407
P577
2014-12-01T00:00:00Z
P5875
P6179
1007378323